三阴性乳腺癌组织中表皮生长因子受体E-黏钙蛋白的表达及意义
摘要
乳腺癌是女性常见的恶性肿瘤之一,其发病率及死亡人数逐年增多。三阴性乳腺癌(triple negative breast cancer),即缺乏雌激素受体(ER)、孕激素受体(PR)及无Her-2的表达,占所有乳腺癌的10%~20%[1],侵袭性强,预后差,对激素拮抗剂和Her-2分子靶向治疗均无效,目前没有针对性治疗方案[2],迫切需要寻找合适的指标指导临床治疗及评估预后。目前,临床有很多蛋白表达和乳腺癌有相关性,本研究通过对表皮生长因子受体(EGFR)、E-黏钙蛋白2种蛋白的表达和三阴性乳腺癌的相关性研究,为临床诊治及评估提供依据。
出处
《实用医技杂志》
2016年第8期863-864,共2页
Journal of Practical Medical Techniques
参考文献10
-
1Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies [J]. J Clin Invest, 2011, 121(7): 2750-2767.
-
2Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: acritical review[J]. J Clin Oncol, 2008, 26( 15): 2568-2581.
-
3Metzger-Filho O, Sun Z, Viale G, et al. Patterns of recurrence and outcome according to breast cancer subtypes in lymph node- negative disease: results from international breast cancer study group trials Ⅷ and IX[J]. J Clin Oncol, 2013, 31(25): 3083- 3090.
-
4Schmadeka R, Harmon BE, Singh M. Triple-negative breast carcinoma: current and emerging concepts [J]. Am J Clin Pathol, 2014, 141(4): 462-477.
-
5Elbaz M, Nasser MW, Ravi J, et al. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer [J]. Mol Oncol, 2015, 9(4): 906-919.
-
6Maiello MR, Amelia D, Bevilaequa S, et al. EGFR and MEK blockade in triple negative breast cancer cells[J]. J Cell Biochem, 2015, 16(8): 811-813.
-
7Singhai R, Patil VW, Jaiswal SR, et al. E-Cadherin as a diagnostic biomarker in breast cancer[J]. N Am J Med Sci, 2011, 3(5) : 227-233.
-
8Thiery JP. Epithelial-mesenchymal transitions in tumour progres- sion[J]. Nat Rev Cancer, 2002, 2(6): 442-454.
-
9陈宇,权毅.E-cadherin在乳腺浸润性导管癌中表达的意义[J].青海医学院学报,2015,36(2):132-136. 被引量:1
-
10Yang YL, Chen MW, Xian L. Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a Meta-analysis [J]. PloS ONE, 2014, 9(6): e99763.
二级参考文献16
-
1美国《AJCC癌症分期手册》第6版(中文版)[J].中国肿瘤,2005,14(12):821-821. 被引量:4
-
2S H. Molecular aspects of adhesion - epigenetic mecha- nisms for inactivation of the E - Cadherin - mediated cell adhe- sion system in cancers [ J ]. Verh Dtsch Ges Pathol, 2000,84 : 28 -32.
-
3No authors. Pathologists' Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer[ J]. Breast Care ,2010,5 ( 3 ) : 185 - 187.
-
4C G, B Z, B A, et al. Comparison of the prognostic value of Scarff - Bloom - Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: Major impor- tance of the mitotic count as a component of both grading systems [ J ]. Anticancer Research, 1998,18 ( 1 B) : 571 - 576.
-
5Goldhirsch A. Personalizing the treatment of women with early breast cancer:highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 [ J ]. Annals of Oncology Official Journal of the European Society for Medical Oncology ,2013,24 (9) :2206 - 2225.
-
6Y S, S H, S H, et al. Cadherin cell - adhesion mole- cules in human epithelial tissues and carcinomas [ J ]. Cancer Res, 1989,49 (8) :2128 - 2133.
-
7Li N, Deng W, Ma J, et al. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E - cadherin expression in gastric cancer [ J ]. Medical Oncology,2015,32 ( 1 ) : 1 - 9.
-
8Yang Y L, Chen M W, Xian L. Prognostic and Clinico- pathological Significance of Downregnlated E - Cadherin Expres- sion in Patients with Non- Small Cell Lung Cancer(NSCLC) :AMeta - Analysis [ J ]. PloS one,2014,9 (6) : e99763.
-
9Pang H, Lu H, Song H, et al. Prognostic values of os- teopontin -c ,E -cadherin and 13 -catenin in breast cancer[ J]. Cancer epidemiology,2013,37 (6) :985 - 992.
-
10Da Silva B B,Dos Santos A R,Pires C G,et al. E- cadherin expression in estrogen receptor - positive and negative breast carcinomas of postmenopansal women [ J ]. Eur J Gynaecol Oncol,2010,31 ( 1 ) :90 - 3.
-
1叶凯.β-catenin和E-cadherin在结直肠癌的表达及临床意义[J].福建医科大学学报,2002,36(3):268-268.
-
2谭丽珊,张振斌.β-连环蛋白,E-钙蛋白,P53在结直肠癌中的表达及意义[J].中国医药指南,2013,11(15):7-8.
-
3杨彩虹,高珊,张雪玉.卵泡刺激素对上皮性卵巢癌细胞株β-黏连蛋白、E-钙蛋白表达的影响[J].宁夏医学杂志,2013,35(9):791-793.
-
4马许辉,康玉华,索智敏,余玲.血清可溶性E钙蛋白与58例胃癌临床病理相关性研究[J].重庆医学,2013,42(14):1595-1597.
-
5黄玲,任琛琛,杨立,白杨,薛景戈,刘灵,李倩.上皮性卵巢癌组织中FOXC1的表达变化及意义[J].山东医药,2017,57(13):13-16. 被引量:7
-
6汪挺,童仕伦.上皮型钙粘蛋白复合体在早期胃癌中表达的研究进展[J].临床外科杂志,2004,12(1):55-56.
-
7张广伟,朱朝阳,李铁强,闫学川.可溶性E钙蛋白与膀胱尿路上皮癌的相关性[J].中国现代医学杂志,2013,23(17):21-24. 被引量:1
-
8王嵬,陈曲,哈敏文.BRCA-1、BAG-1在三阴性乳腺癌中的表达关联研究[J].中国医药指南,2014,12(22):252-253. 被引量:1
-
9李远志.三阴性乳腺癌的临床研究进展[J].淮海医药,2011,29(4):376-376. 被引量:2
-
10陈颉,洪日.三阴乳腺癌的临床研究新进展[J].健康必读(下),2012(1):230-231.